September 14, 2019
Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.
Read More
January 30, 2019
Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk
Read More
January 30, 2019
“Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC”
Read More
January 30, 2019
“Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC”
Read More
January 30, 2019
Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting
Read More
January 30, 2019
Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy
Read More
January 30, 2019
Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib
Read More
January 30, 2019
Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma
Read More
January 30, 2019
Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy
Read More
January 30, 2019
Register of Telaprevir and Boceprevir in Routine Clinical Practice
Read More
January 30, 2019
Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C
Read More
January 30, 2019
Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs
Read More
Load More
X